After the first developed PARP inhibitor, olaparib, multiple PARP inhibitors such as niraparib, veliparib, and talazoparib were subsequently developed and tested in different phases of clinical trials
Stable gastric pentadecapeptide BPC is an anti-ulcer peptidergic
A negative PCAC outcome today leaves that market intact as the only practical access point for these compounds
[DOI] [PMC free article] [PubMed] [Google Scholar] [10].Guarnieri JW, Angelin A, Murdock DG, Schaefer P, Portluri P, Lie T, et al
This study explored the roles of the two independent ferroptosis axes, ACSL4/GPX4 and FSP1, in oxalate-induced renal tubular epithelial cell injury, aiming to provide novel therapeutic approaches for treating oxalate-induced AKI